Tredje AP-fonden’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-61,000
Closed -$4.03M 480
2024
Q3
$4.03M Sell
61,000
-133,156
-69% -$8.79M 0.04% 234
2024
Q2
$17.9M Sell
194,156
-22,000
-10% -$2.03M 0.17% 102
2024
Q1
$20.7M Buy
216,156
+47,000
+28% +$4.49M 0.21% 93
2023
Q4
$12.9M Buy
169,156
+24,500
+17% +$1.87M 0.16% 107
2023
Q3
$10M Sell
144,656
-8,029
-5% -$556K 0.15% 107
2023
Q2
$14.4M Sell
152,685
-40,820
-21% -$3.85M 0.2% 97
2023
Q1
$16M Buy
193,505
+41,216
+27% +$3.41M 0.25% 92
2022
Q4
$11.4M Buy
152,289
+90,383
+146% +$6.74M 0.19% 101
2022
Q3
$5.12M Sell
61,906
-52,733
-46% -$4.36M 0.11% 148
2022
Q2
$10.9M Hold
114,639
0.27% 83
2022
Q1
$13.5M Buy
114,639
+24,400
+27% +$2.87M 0.27% 80
2021
Q4
$11.7M Buy
90,239
+8,239
+10% +$1.07M 0.23% 95
2021
Q3
$9.28M Buy
82,000
+55,500
+209% +$6.28M 0.19% 110
2021
Q2
$2.75M Hold
26,500
0.06% 166
2021
Q1
$2.22M Hold
26,500
0.05% 176
2020
Q4
$2.42M Sell
26,500
-162,662
-86% -$14.8M 0.06% 164
2020
Q3
$15.1M Hold
189,162
0.49% 52
2020
Q2
$13.1M Hold
189,162
0.54% 47
2020
Q1
$11.9M Buy
189,162
+136,998
+263% +$8.61M 0.62% 43
2019
Q4
$4.06M Sell
52,164
-2,478
-5% -$193K 0.21% 125
2019
Q3
$4.01M Sell
54,642
-4,758
-8% -$349K 0.19% 138
2019
Q2
$3.66M Sell
59,400
-3,648
-6% -$225K 0.17% 148
2019
Q1
$4.02M Buy
63,048
+14,901
+31% +$950K 0.21% 124
2018
Q4
$2.46M Buy
48,147
+2,730
+6% +$139K 0.15% 165
2018
Q3
$2.64M Buy
45,417
+7,260
+19% +$421K 0.13% 194
2018
Q2
$1.85M Sell
38,157
-21,708
-36% -$1.05M 0.06% 293
2018
Q1
$2.78M Sell
59,865
-450
-0.7% -$20.9K 0.1% 248
2017
Q4
$2.27M Sell
60,315
-390
-0.6% -$14.7K 0.08% 290
2017
Q3
$2.21M Sell
60,705
-13,170
-18% -$480K 0.08% 295
2017
Q2
$2.91M Sell
73,875
-19,500
-21% -$769K 0.11% 231
2017
Q1
$2.93M Sell
93,375
-24,639
-21% -$773K 0.12% 232
2016
Q4
$3.69M Buy
118,014
+9,066
+8% +$283K 0.16% 181
2016
Q3
$4.38M Buy
108,948
+18,102
+20% +$727K 0.2% 126
2016
Q2
$3.02M Buy
90,846
+87,426
+2,556% +$2.91M 0.14% 172
2016
Q1
$120K Buy
+3,420
New +$120K 0.01% 381